Clinically significant anticardiolipin antibodies associated with COVID-19
Sami Hossri, Mahmoud Shadi, Zaid Hamarsha, Rick Schneider, Dany Elsayegh
Topics & Concepts
MedicineCoagulopathyCoronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antiphospholipid syndromeCritically illIntensive care medicine2019-20 coronavirus outbreakAnticardiolipin antibodiesAntibodyIntensive care unitDiseaseInternal medicineImmunologyVirologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesDermatological and COVID-19 studiesHeparin-Induced Thrombocytopenia and Thrombosis